Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew P. Young currently holds 59,000 shares of Jazz Pharmaceuticals plc (JAZZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew P. Young has been a net seller of JAZZ stock. They have purchased $0 and sold $3.5M worth of shares.
Matthew P. Young's most recent insider trade was on Jun 17, 2026, when they sold 59,000 shares at $0.00 per share.
Matthew P. Young serves as Executive at Jazz Pharmaceuticals plc (JAZZ). They have executed 62 insider transactions totaling $3.5M over their tenure at the company.
Matthew P. Young holds the position of Executive at Jazz Pharmaceuticals plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Matthew P. Young has shown a selling trading pattern, with $0 in total purchases and $3.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthew P. Young was on Jun 1, 2018, when they sold $850.2K worth of JAZZ shares. This transaction involved 5,000 shares at $170.04 per share.
Matthew P. Young currently owns 59,000 shares of Jazz Pharmaceuticals plc (JAZZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew P. Young's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew P. Young has 62 Form 4 filings on record as an insider at Jazz Pharmaceuticals plc.
Set alerts for Matthew P. Young and 40,000+ other insiders.